![Page 1: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/1.jpg)
1
Prevention of Infections of Prosthetic Joints
Ilker UçkayInfection Control ProgrammeGeneva University Hospitals
Hôpitaux Universitaires de Genève
![Page 2: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/2.jpg)
2
Relative risks of SSI
Northern France 1998-2000, 67 wards, 26,094 patients
Rioux et al, ICHE 2006
![Page 3: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/3.jpg)
3
Clean orthopaedic surgery
Primary arthroplasties
0.8% Norwegian Arthroplasty Register (73,000 arthroplasties)
0.5% Deep arthroplasty infection Norway (22,170)
0.9% Finland (4628 arthroplasties)
0.5% Geneva (6101 arthroplasties)
Havelin et al, Acta Orthop Scand 2000
Engesaeter et al, ACS 2003
Paavolainen et al, Acta Orthop Scand 1991
Uçkay et al, J Infect 2009
![Page 4: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/4.jpg)
4
Clean orthopaedic surgery
3.9% Femoral osteosynthesis3.6% Elbow arthroplasties1.2% Hand surgery1.6% Foot & ankle surgery 0.8% Primary arthroplasties0.1% Arthroscopies4-11% PIN care1.3% Hallux valgus - Lapidus
Kleinert et al, JBJS Am ‘97
Zgonis et al, J FSAS 2004
Uçkay et al, J Infect ‘09
Müller-Rath et al, Arthroskopie 2008
Merrer et al, ICHE ‘07
Celli et al, JBJS Am 2009
Reigstad et al, Knee Surg Traum Arthrosc ‘06
Popelka et al, Acta Chir orthop Traumatol Cech 2008
![Page 5: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/5.jpg)
5
1. Diagnosis and treatment
2. Prevention of SSI, general aspects
3. Particularities in orthopedic surgery
Structure of the presentation
![Page 6: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/6.jpg)
1700 /μl
65%sens. 94%spec. 88% sens. 97%
spec. 98%
total leuc count
neutrophils
Diagnostics in low-grade infections
![Page 7: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/7.jpg)
Sonication Mass spectrometry
Microcalorimetry Molecular methods 7
![Page 8: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/8.jpg)
8
![Page 9: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/9.jpg)
![Page 10: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/10.jpg)
![Page 11: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/11.jpg)
Zimmerli et al. N Engl J Med 2004
![Page 12: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/12.jpg)
![Page 13: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/13.jpg)
Microbiology of 578 prosthetic joint infections seen at Mayo Clinic between 1992-1997
Microorganism %Coagulase-negative staphylococci 30 %S. aureus 23 %Polymicrobial 12 %Unknown 11 %Streptococci 9 %Gram-negative bacilli 6 %Anaerobes 4 %Enterococci 3 %Other 2 %
Steckelberg et al. Prosthetic Joint Infections, Infections Associated with Indwelling Medical Devices, 3rd edition, ASM Press, 2000
![Page 14: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/14.jpg)
Zimmerli et al, JAMA 1998
![Page 15: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/15.jpg)
![Page 16: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/16.jpg)
• linzolide • quinopristine-dalfopristine• pristinamycine• daptomycin, • tigecyclin, • minocyclin,• New quinolones,
Studies of equivalencenot superior to « old combinations »
Uçkay, Lew. MRSA bone infections. Nova Science 2009.
New molecules
![Page 17: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/17.jpg)
If implant removedclindamycine 3 x 600 mg, ciprofloxacine 2 x 750 mg
Combinationsciprofloxacine 2 x 500 mg - rifampicine 1 x 600 mgacide fusidique 3 x 500 mg - rifampicine 1 x 600 mgcotrimoxazole 2-3 x forte - rifampicine 1 x 600 mg
Antibiotics in Geneva
Uçkay, Lew. In Karchmer. Osteomyelitis 2010
![Page 18: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/18.jpg)
No studies. Experts‘ opinion
As a principle 6-12 weeksindependently of bone or bacteria
Exceptions:Special pathogens: Tbc, actinomyces, fungi, etc.
Duration of antibiotic therapy
Lew, Waldvogel, Lancet 2004Zimmerli, Tampuz et al, various publications
![Page 19: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/19.jpg)
19
![Page 20: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/20.jpg)
Multivariate analysis for outcome Cure
•Retention with debridement (OR 0.3, 0.1-1.1) •Two-stage exchange (OR 1.1, 0.2-4.8) •Number of surgical debridements (OR 0.9, 0.4-1.9) •6 weeks’ antibiotic treatment (OR 2.0, 0.9-7.8) •Duration of i.v. antibiotic course (OR 1.0, 1.0-1.0)
![Page 21: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/21.jpg)
21
1. Diagnosis and treatment
2. Prevention of SSI, general aspects
3. Particularities in orthopedic surgery
Structure of the presentation
![Page 22: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/22.jpg)
Uçkay, Pittet et al, Ann Med 2009
![Page 23: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/23.jpg)
23
![Page 24: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/24.jpg)
24Uçkay et al, J Infect 2009
Haematogenous infections
![Page 25: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/25.jpg)
25
Risk factors for SSI (selection)
Diabetes mellitus OR 4.5, 2.4-9.3
Obesity >30 BMI OR 4.1, 1.1-19.0
Change of surgeon OR 2.9, 2.0-4.0
Wound class OR 2.6, 2.2-3.0
Infect. prior surgery OR 2.4, 1.6-3.7
Hyperglycaemia OR 2.3, 1.3-4.0
Drains >3 days OR 2.2, 1.4-3.4
Trussel, Am J Surg 2008
Lübbeke et al, Arthrit Rheum 08
Park et al, Transplantation 2009
Rioux et al, ICHE 2006
Petrosillo et al, BMC Infect Dis 08
Beldi et al, Am J Surg 2009
Haridas et al, Surgery 2008
![Page 26: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/26.jpg)
26
Risk factors for SSI (selection)
ASA-Score >2 pts OR 1.9, 1.6-2.2
Loud noise OR 1.9, 1.3-2.6
Hectic movements OR 1.8, 1.1-3.0
Duration surg >75% OR 1.8, 1.2-2.8
Emergency surgery OR 1.7, 1.2-2.4
Age >65 years OR 1.3, 1.1-1.5
Rioux et al, ICHE 2006
Rioux et al, ICHE 2006
Beldi et al, Am J Surg 2009
Beldi et al, Am J Surg 2009
Haridas et al, Surgery 2008
Petrosillo et al, BMC Infect Dis 08
![Page 27: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/27.jpg)
For orthopaedics
•Polyarthritis •Revision
27
![Page 28: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/28.jpg)
4 cornerstones
28
![Page 29: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/29.jpg)
29
![Page 30: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/30.jpg)
![Page 31: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/31.jpg)
31
Antibiotic prophylaxis …
• No benefit >24 h• No benefit of continuous vs. intermittent
infusion
• No threshold for routine vancomycine prophylaxis in settings with endemicity for methicillin-resistant staphylococci.
• No evidence that vancomycin is superior to cephalosporins.
McDonald et al, Aust N Z J Surg 1998
Suffoletta et al, Pharmacotherapy 2008
Prokuski, J Am Acad Orthop Surg 2008
![Page 32: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/32.jpg)
32
Timing
Steinberg et al. Ann Surg 2009
![Page 33: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/33.jpg)
33Prokuski. J Am Acad Orthop Surg 2008
Choice of antibiotic agents
![Page 34: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/34.jpg)
![Page 35: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/35.jpg)
![Page 36: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/36.jpg)
![Page 37: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/37.jpg)
Postponing in case of remote infections ?
Experience of surgeons ?
37
![Page 38: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/38.jpg)
Does it matter ?
maybe ….38
![Page 39: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/39.jpg)
Screening for S. aureus
39
![Page 40: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/40.jpg)
![Page 41: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/41.jpg)
41
Walz et al, Arch Surg 2006Kurz et al, NEJM 1996
Intraoperative normoglycaemia (<200mg/dL)SSI 20% vs. 52%, while Hb A1c and diabetes mellitus were not associated
Park et al, Transplantation 2009
Ambiru et al, J Hosp Infect 2008
![Page 42: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/42.jpg)
![Page 43: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/43.jpg)
43
Active surveillance
Courtesy: Astagneau, SFHH 2007
![Page 44: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/44.jpg)
44
Rioux et al, J Hosp Infect 2007
![Page 45: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/45.jpg)
45
Multimodal approachTimely antibiotic prophylaxis, strict glycaemia control, no shaving SSI 1.5% vs. 3.5% in controls
100k lives campaign(antibiotic prophylaxis, glycaemia control, normothermia)SSI from 2.3% to 1.7% (-27%)
SCIP project & Safety Checklist
100k lives campaign
Trussel et al, Am J Surg 2008
![Page 46: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/46.jpg)
Things that do matter ?
46
![Page 47: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/47.jpg)
47
Before surgery
Disinfection in circles vs. back-and forthNo difference.
Preoperative bathing and showering.Cochrane review, 6 trials, 10,000 participantsNo evidence vs. placebo RR 0.9, 0.8-1.1.
Haïr removal. Meta-analysis of 4 trials.Inconclusive. Immediately before operation.
Stonecypher. Crit Care Nurs Q 2009
Webster et al, Cochrane Database of Systematic Reviews 2007
Niël-Weise et al. ICHE 2005Mangram et al, ICHE 1999
![Page 48: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/48.jpg)
48
During and afterLaparoscopy vs. laparotomy. No evidence
Double-gloving 26 trials. Inconclusive
Staples vs. sutures. No difference
Use of drains. No evidence
Pin site care. 6 trials, 349 patients.No regimen (daily vs. weekly, cleansing vs. no cleansing) is superior to others
Anderson et al. UpToDate 2009
Mullen et al, Can J Cardiol 1999Chughtai et al, Can J Cardiol 2000
Tanner et al, Cochrane Database of Systematic Reviews 2006
Gaines et al. Orthopedics 2008
Lethaby et al. Cochrane Database of Systematic Reviews 2008
![Page 49: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/49.jpg)
49
Laminar airflow
Laminar airflow reduces bacterial burden in the air
Retrospective analysis in KISS system(63 hospitals, 100,000 procedures).
No reduction of SSI with laminar airflow vs. no laminar airflow. OR 1.63, 1.06-2.52.No information about individual antibiotic prophylaxis, normothermia, obesity etc.
Brandt et al, Ann Surg 2008
Whyte et al, J Hosp Infect 1982
![Page 50: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/50.jpg)
50
Public reportingMandatory or planned in several US states
CDC reviewNo studies have investigated SSI reduction as outcome. None compared costs.
HICPAC recommends possible public reporting of antibiotic prophylaxis-related parameters, and SSI of selected operations.Key questionsMotivation for HCW or hospitals ?What to do with unexpected consequences ?
McKibben et al, Am J Infect Control 2005
Humphreys et al, Clin Microbiol Infect 2008
![Page 51: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/51.jpg)
51
Sparse literature
Most SSI are believed to be acquired during surgery ?- SSI diminution in operating room- airborne (opinion 1970s)
Charnley. Clin Orthop Relat Res 1972
Lidwell et al, BMJ 1982Lindberg. Lakartidningen 1979
The proportion of SSI acquired in the operating theatre vs. acquired afterwards, is unknown
Ayliffe. Rev Infect Dis 1991
![Page 52: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/52.jpg)
52
Author Harbarth, JAMA 2008
Robicsek, Annals 2008
Jeyaratnam, BMJ 2008
Keshtgar, Br J Surg 2008
Country Switzerland USA UK UK
Setting Surgery Hospital-wide Geriatrics, oncology, surgery
Surgery
Design Cross-over Before-after Cross-over Before-after
Control group Yes No Yes No
Admission MRSA prevalence
5.1% 6.3% 6.7% 4.5%
CONCLUSION Screening did not reduceMRSA infections
Admission screening reducedMRSA disease
Universal MRSA screening is not recommended
MRSA screening reduced staphyloc. BSI
Harbarth et al. J Am Coll Surg 2008
MRSA screening on admisson
![Page 53: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/53.jpg)
53
![Page 54: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/54.jpg)
54
3.4
7.7
1.1
4.9
0
5
10
Intervention Placebo
SA in
fect
ion
rate
(%)
All S.aureus NI Deep SSI
S. aureus screening & decolonization
Bode et al NEJM 2010
![Page 55: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/55.jpg)
55
Nasal mupirocin
8 RCTs included
Effect of mupirocin nasal ointment on S. aureus infections
Significant reduction of the S. aureusinfection rate
RR 0.6, 95% CI 0.43-0.70
Van Rijen et al, Cochrane Database Syst Rev. 2008
![Page 56: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/56.jpg)
56
Nasal mupirocin ?
• Reduced MSSA carriage in 615 orthopaedic patients, but not SSI (not even due to MSSA !)
• No benefit in general surgery
• Meta-analysis in general surgeryMupirocin vs. no mupirocin; SSI 8.4% vs. 8.1%
Kalmeijer et al, CID 2002
Kallen et al, ICHE 2005
Perl et al, NEJM 2002
![Page 57: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/57.jpg)
Single centresHistorical controls (before-after studies)
Screening & decolonisation (mupirocin, chlorhexidin) or (mupirocin, triclosan)
significantly beneficiary for MRSA, not MSSA
Caveat: No case-mix ajustements57
![Page 58: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/58.jpg)
58
![Page 59: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/59.jpg)
59
![Page 60: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/60.jpg)
60
![Page 61: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/61.jpg)
61
![Page 62: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/62.jpg)
Single centreProspective- two groups
Screening & decolonisation (mupirocin, 5d chlorhexidin)vs.no intervention
Results: no vs. 12 SSI due to S. aureusEconomic gain of $230,000 for the hospital
62
![Page 63: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/63.jpg)
In our case
No revision, no polyarthritisMassive early PJIAcquired in operating theatreExperienced surgeonsCorrect antibiotic prophylaxis
…..?63
![Page 64: Prevention of Infections of Prosthetic JointsIlker Uçkay Infection Control Programme Geneva University Hospitals Hôpitaux Universitaires de Genève. 2 Relative risks of SSI Northern](https://reader034.vdocuments.us/reader034/viewer/2022050108/5f46821f6720680dc26421d8/html5/thumbnails/64.jpg)
64
Thank you very much for your attention
AcknowledgmentsParham Sendi, Stephan Harbarth, Hazel Morse, Hugo Sax, Didier Pittet